GROWTH
Top line stable.
+1.4% YoY versus +3.3% prior. 3y CAGR +4.3%.
+1.4%
Colgate-Palmolive Company CL
Consumer Staples · Market Cap: $71.6B
Live price unavailable
Fundamentals as of 2026-03-31
We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Consumer Staples · Market Cap: $71.6B
Live price unavailable
Fundamentals as of 2026-03-31
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
The Question
2 of 2 legendary models say BUY CL.
What would legendary investors pay for CL?
These figures are not quotes or opinions from Buffett, Graham, Lynch or the other investors. They are our own estimates, computed by applying the intrinsic-value formulas each investor is known for to this company’s financials.
For educational purposes only. Not a recommendation to buy or sell securities.
+1.4% YoY versus +3.3% prior. 3y CAGR +4.3%.
+1.4%Net margin 10.5% versus 14.4% prior (−3.9pp). Operating 21.3%.
10.5%P/E 34.4x — 7% above the 5y median of 32.3x. Forward 23.3x hints at EPS expansion next year.
34.4xColgate-Palmolive Company's ROE and debt-to-equity are non-meaningful — large accumulated buybacks have driven stockholders' equity below zero, so the ratio denominators are uninterpretable. Operating margin and free cash flow are the better lenses here.
Financial story
Colgate-Palmolive Company's ROE and debt-to-equity are non-meaningful — large accumulated buybacks have driven stockholders' equity below zero, so the ratio denominators are uninterpretable. Operating margin and free cash flow are the better lenses here.
Bottom line: CL is rated BUY by all 2 legendary models, 44% below avg fair value $160, but earns a C sector grade (49/100) in Consumer Staples. Whether the premium is justified depends on which lens you trust. Drill into the valuation breakdown and sector ranking for the full picture.
CL trades at 34.0x earnings. Sector context and per-investor signals are in the valuation tab.
CL and MNST differ on P/E, ROE, and revenue growth. See the full CL vs MNST compare matrix.
Buffett and Munger evaluate CL against their respective frameworks. Per-model fair value and reasoning are in the valuation tab.
CL's P/E ratio is 34.0x. 5-year P/E history is in the financials tab.
2 of 2 legendary models say BUY. Full breakdown by investor and signal is in the valuation tab.
CL's earnings calendar and history are tracked in the financials tab. Specific dates depend on company-published guidance.
How does CL compare?
See exactly where CL ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingCL sits at #32 in Consumer Staples with a C grade (49/100).
